| Announce Date | 12/09/2025 |
| EPS Normalized Actual | $0.29 (Beat by $0.12) |
| EPS GAAP Actual | $0.29 (Beat by $0.12) |
| Revenue Actual | $0.057199B |
| Revenue Surprise | Beat by $57.199M |
| Announce Date | 10/30/2025 (Pre-Market) |
| EPS Normalized Estimate | $0.405 |
| EPS GAAP Estimate | $0.405 |
| Revenue Estimate | $0.063782B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Apr 2027 | 0.75 | 10.28 | 0.5625 | 0.9375 | -1 |
| Apr 2026 | -0.45 | -17.13 | -0.3375 | -0.5625 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | 0.16 | -0.245 | 0.057199B | -5.3% | -6.58M |
| FQ3 2025 (Jul 2025) | -0.54 | -0.525 | 0.029702B | -40.2% | -15.17M |
| FQ2 2025 (Apr 2025) | -0.08 | -0.09 | 0.061942B | 25.26% | 11.77M |
| FQ1 2025 (Jan 2025) | 0.0132 | -0.1368 | 0.058505B | 8.68% | 3.01M |
| FQ4 2024 (Oct 2024) | 0.24 | -0.06667 | 0.060232B | 3.82% | 0.18M |
| FQ3 2024 (Jul 2024) | -0.18 | -0.19 | 0.041643B | -4.33% | -4.42M |
| FQ2 2024 (Apr 2024) | -0.41 | -0.41 | 0.046298B | 100% | 46.3M |
| FQ1 2024 (Jan 2024) | -0.23 | -0.23 | 0.053425B | 100% | 53.43M |
FQ4 Announce Date
10/30/2025 (Pre-Market)
Consensus EPS Estimates
0.405
Consensus Revenue Estimates
0.063782B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2027 (Jan 2027) | 0.26 | -- | 0.26 | 0.26 | 1 |
| FQ4 2026 (Oct 2026) | 0.31 | 48.39 | 0.31 | 0.31 | 1 |
| FQ3 2026 (Jul 2026) | -0.16 | -237.5 | -0.16 | -0.16 | 1 |
| FQ2 2026 (May 2026) | -0.03 | -166.67 | -0.0307183 | -0.0292817 | 0 |
| FQ1 2026 (Jan 2026) | 0.2 | 93.4 | 0.19254 | 0.20746 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2027 (Jan 2027) | 0.06B | -- | 0.06B | 0.06B | 1 |
| FQ4 2026 (Oct 2026) | 0.05B | -6.75 | 0.05B | 0.05B | 1 |
| FQ3 2026 (Jul 2026) | 0.04B | 24.29 | 0.04B | 0.04B | 1 |
| FQ2 2026 (May 2026) | 0.05B | -12.78 | 0.05B | 0.06B | 0 |
| FQ1 2026 (Jan 2026) | 0.06B | 5.79 | 0.06B | 0.06B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
0
EPS # of Misses
8
EPS # of in-lines
0
Revenue # of Beats
5
Revenue # of Misses
3
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | 0.405 | 0.16 | -0.245 | -153.13% |
| FQ3 2025 (Jul 2025) | -0.015 | -0.54 | -0.525 | 97.22% |
| FQ2 2025 (Apr 2025) | 0.01 | -0.08 | -0.09 | 112.5% |
| FQ1 2025 (Jan 2025) | 0.15 | 0.0132 | -0.1368 | -1036.36% |
| FQ4 2024 (Oct 2024) | 0.30667 | 0.24 | -0.06667 | -27.78% |
| FQ3 2024 (Jul 2024) | 0.01 | -0.18 | -0.19 | 105.56% |
| FQ2 2024 (Apr 2024) | -0.41 | -0.41 | 100% | |
| FQ1 2024 (Jan 2024) | -0.23 | -0.23 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | $0.06B | $0.06B | $-6.58M | -11.51% |
| FQ3 2025 (Jul 2025) | $0.04B | $0.03B | $-15.17M | -51.06% |
| FQ2 2025 (Apr 2025) | $0.05B | $0.06B | $11.77M | 19% |
| FQ1 2025 (Jan 2025) | $0.06B | $0.06B | $3.01M | 5.14% |
| FQ4 2024 (Oct 2024) | $0.06B | $0.06B | $0.18M | 0.29% |
| FQ3 2024 (Jul 2024) | $0.05B | $0.04B | $-4.42M | -10.61% |
| FQ2 2024 (Apr 2024) | $0B | $0.05B | $46.3M | 100% |
| FQ1 2024 (Jan 2024) | $0B | $0.05B | $53.43M | 100% |